GlassScriptPhysician profile
Raymond E Esquieres
NPI 1932180924
$1,122.15
in general payments reported to CMS, 2019-2025
25 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $260 · 2020: $77.06 · 2021: $167 · 2022: $264 · 2023: $88.65 · 2024: $105 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $175.42 | 2019-2022 | |
| Depuy Synthes Sales INC. | $114.47 | 2019-2025 | Monovisc, Orthovisc |
| Scilex Pharmaceuticals INC. | $102.60 | 2019-2022 | |
| Pfizer INC. | $100.83 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $64.72 | 2019-2025 | Euflexxa |
| Zimmer Biomet Holdings, INC. | $61.33 | 2023 | Gel-One Cross-Linked Hyaluronate |
| Pacira Pharmaceuticals Incorporated | $50.34 | 2021-2025 | Exparel, Zilretta |
| Avanos Medical | $49.36 | 2022-2023 | Trivisc Sodium Hyaluronate |
| Bioventus LLC | $47.71 | 2021-2024 | Durolane |
| Si-Bone, INC. | $47.15 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $43.14 | 2022 | |
| Stryker Corporation | $40.70 | 2020-2022 | |
| Smith+Nephew, INC. | $27.98 | 2019 | |
| Tersera Therapeutics LLC | $24.68 | 2019 | |
| Abbott Laboratories | $23.42 | 2024 | Proclaim |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $16.97 | 2025 | |
| Djo, LLC | $16.93 | 2025 | Donjoy |
| Cerapedics INC. | $15.30 | 2022 | |
| Endo USA, INC. | $15.26 | 2024 | Xiaflex |
| Assertio Therapeutics, INC. | $14.98 | 2019 | |
| Highridge Medical LLC | $14.47 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Ebi, LLC | $14.47 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Next Science LLC | $13.33 | 2021 | |
| Zyla Life Sciences, INC. | $13.33 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Esquieres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.